^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

CT101a

i
Other names: CT101a, cytokine-induced memory-like NK cells
Associations
Trials
Company:
Shanghai Zeke Biotech, Zhejiang University
Drug class:
NK cell stimulant
Related drugs:
Associations
Trials
over1year
NK Cell Therapy for AML (clinicaltrials.gov)
P1, N=3, Terminated, Zhejiang University | N=18 --> 3 | Trial completion date: Jun 2025 --> Apr 2023 | Recruiting --> Terminated | Trial primary completion date: Dec 2024 --> Aug 2022; A new study is planed to replace the current study due to IP upgrade
Enrollment change • Trial completion date • Trial termination • Trial primary completion date
|
CT101a